Fluticasone Propionate
Who holds supplier records for Fluticasone Propionate? 27 organisations hold a current record for Fluticasone Propionate: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 19 of them hold a valid EU Certificate of Suitability (20 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (6), China (4), Italy (4), Israel (2) and 7 other countries (7); not recorded for 4.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Fluticasone Propionate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/fluticasone-propionate
Reading the evidence
- 27 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 16 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Fluticasone Propionate expires 23 Feb 2036. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (27)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Fluticasone Propionate. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 30417, 15774, 33172 · latest filing Nov 2018
- Aurisco Pharmaceutical Co.,ltdChinaCEP Company GMP cert on recordActive DMF 34273, 20212 · latest filing Nov 2019
- CORAL DRUGS PVT LTDIndiaCEP Company GMP cert on recordActive DMF 21879, 36315 · latest filing Nov 2021
- GLAXOSMITHKLINE LLCAlso filed as GLAXOSMITHKLINEActive DMF 32952, 31534 · latest filing Aug 2018
- AARTI PHARMALABS LIMITEDIndiaCEPActive DMF 22980 · latest filing Jul 2009
- BREATHGREEN PHARMACEUTICAL CO LTDCEPActive DMF 38759 · latest filing Aug 2023
- CURIA SPAIN SAUSpainCEP Company GMP cert on recordActive DMF 37297 · latest filing Sept 2022
- Farmabios S.p.A.ItalyCEP Company GMP cert on recordActive DMF 20463 · latest filing Apr 2007
- Hovione FarmaCiencia SAPortugalCEP Company GMP cert on recordActive DMF 16334 · latest filing Dec 2002
- INDUSTRIALE CHIMICA SRLItalyCEP Company GMP cert on recordActive DMF 23427 · latest filing Jan 2010
- NEWCHEM SPAItalyCEP Company GMP cert on recordActive DMF 22236 · latest filing Nov 2008
- SHANDONG SIRUI PHARMACEUTICAL CO LTDCEPActive DMF 35359 · latest filing Mar 2021
- STERLING SPAItalyCEP Company GMP cert on recordActive DMF 16423 · latest filing Feb 2003
- TAPI NL BVNetherlandsCEPActive DMF 15745 · latest filing Nov 2001
- VAMSI LABS LTDIndiaCEP Company GMP cert on recordActive DMF 40285, 42812 · latest filing Nov 2025
- WAVELENGTH ENTERPRISES LTDIsraelCEP Company GMP cert on recordActive DMF 15456 · latest filing May 2001
- Amphastar Nanjing PharmaceuticalsChinaActive DMF 29454 · latest filing Jun 2015
- Apotex Inc.CanadaActive DMF 35393 · latest filing Dec 2020
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChina Company GMP cert on recordActive DMF 44220 · latest filing May 2026
- Lupin LimitedIndia Company GMP cert on recordActive DMF 29975 · latest filing Dec 2015
- SHANDONG RISEN-SUN PHARMACEUTICAL CO LTDActive DMF 44395 · latest filing Jun 2026
- Taro Pharmaceutical Industries Ltd.Israel Company GMP cert on recordActive DMF 17618 · latest filing Aug 2004
- TIANJIN TIANYAO PHARMACEUTICALS CO LTDChinaActive DMF 34126 · latest filing Dec 2019
- FinlandCEP Company GMP cert on record
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 17544 · latest filing Jul 2004
- GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITEDUnited KingdomCEPValid CEP holder (EDQM); not necessarily the manufacturer
- EUROAPI FRANCE VertolayeFranceCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (20)
Certificates of Suitability on the EDQM register for Fluticasone Propionate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 33 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 2026-230 - Rev 00 Fluticasone propionate, Sicor Italy- 6706MO | Aug 2026 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2020-075 - Rev 03 Fluticasone propionate, Modified Process II, Micronised | Jul 2026 | — |
| FERMION OY Espoo | FI | CEP 2020-008 - Rev 03 Fluticasone propionate, Micronised, non-micronised | Jun 2026 | Inspected Feb 2026 Finland |
| NEWCHEM S.p.A. Milan | IT | CEP 2006-093 - Rev 06 Fluticasone propionate, Micronised, non-micronised | Jun 2026 | — |
| HOVIONE FARMACIENCIA S.A. Loures | PT | CEP 2005-160 - Rev 03 Fluticasone propionate, Micronised | Dec 2025 | Inspected Apr 2025 Portugal |
| VAMSI LABS LIMITED Solapur | IN | CEP 2020-078 - Rev 03 Fluticasone propionate, Micronised | Jun 2025 | — |
| GLAXOSMITHKLINE RESEARCH & DEVELOPMENT LIMITED London | GB | CEP 2018-229 - Rev 03 Fluticasone propionate, Micronised | Apr 2025 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | CEP 2013-315 - Rev 02 Fluticasone propionate | Feb 2025 | Inspected Feb 2026 Spain |
| WAVELENGTH ENTERPRISES LTD. Petah Tikva | IL | CEP 2007-192 - Rev 09 Fluticasone propionate | Nov 2024 | — |
| BREATHGREEN PHARMACEUTICAL CO. LTD. Zaozhuang City | CN | CEP 2023-292 - Rev 00 Fluticasone propionate, Micronised | Jul 2024 | — |
| FARMABIOS S.p.A Gropello Cairoli | IT | CEP 2008-117 - Rev 02 Fluticasone propionate, Micronised | May 2024 | Inspected Jul 2026 Italy |
| SHANDONG SIRUI PHARMACEUTICAL CO., LTD. Heze | CN | CEP 2022-282 - Rev 00 Fluticasone propionate | May 2024 | — |
| AURISCO PHARMACEUTICAL CO., LTD. Tiantai | CN | CEP 2023-360 - Rev 00 Fluticasone propionate, Process FCPB | Mar 2024 | Inspected Dec 2023 Germany |
| CORAL DRUGS PRIVATE LIMITED New Delhi | IN | R0-CEP 2021-492 - Rev 00 Fluticasone propionate, Process 1 | Jun 2023 | — |
| EUROAPI FRANCE Vertolaye | FR | R1-CEP 2018-040 - Rev 00 Fluticasone propionate, Non-micronised, micronised | May 2023 | — |
| AARTI PHARMALABS LIMITED Mulund (W), Mumbai | IN | R1-CEP 2007-262 - Rev 03 Fluticasone propionate | Oct 2022 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2012-001 - Rev 02 Fluticasone propionate, Process II, micronised, grades I and II | Mar 2022 | — |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | R1-CEP 2004-231 - Rev 04 Fluticasone propionate | Dec 2019 | — |
| INDUSTRIALE CHIMICA S.R.L. Saronno | IT | R1-CEP 2012-024 - Rev 00 Fluticasone propionate | Feb 2019 | — |
| STERLING S.p.A. Solomeo Di Corciano | IT | R1-CEP 2005-268 - Rev 02 Fluticasone propionate | Feb 2016 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Fluticasone Propionate are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- MYLAN LABORATORIES LTDInactive DMF 28264 · filed Jun 2014
- India · Inactive DMF 19115 · filed Jan 2006
- Taiwan · Inactive DMF 15686 · filed Oct 2001
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (28 listed products contain Fluticasone Propionate). The latest listed patent expires 23 Feb 2036. The latest listed exclusivity runs to 15 Mar 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Fluticasone Propionate is a synthetic glucocorticoid with anti-inflammatory and vasoconstrictive properties. It is commonly used in the treatment of respiratory disorders such as asthma and allergic rhinitis.
Chemical identity
- IUPAC name
- [(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
- Canonical SMILES
- CCC(=O)O[C@@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)C)C(=O)SCF
- InChIKey
- WMWTYOKRWGGJOA-CENSZEJFSA-N
- Synonyms
- Flonase API, advair component fluticasone propionate, armonair respiclick, cci-18781, cci18781, cutivate, dymista component fluticasone propionate, flixotide, flonase, flovent, fluticasone-17-propionate, nsc-759889
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Corticosteroid
- Mechanism of action
- Corticosteroid Hormone Receptor Agonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Fluticasone Propionate?
27 organisations hold an active US FDA Type II Drug Master File or a CEP for Fluticasone Propionate: Cipla Limited (India), Aurisco Pharmaceutical Co.,ltd (China), CORAL DRUGS PVT LTD (India), GLAXOSMITHKLINE LLC, AARTI PHARMALABS LIMITED (India), BREATHGREEN PHARMACEUTICAL CO LTD, CURIA SPAIN SAU (Spain) and Farmabios S.p.A. (Italy), and 19 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Fluticasone Propionate Drug Master Files are active?
Cipla Limited (DMF 30417, 15774), Aurisco Pharmaceutical Co.,ltd (DMF 34273, 20212), CORAL DRUGS PVT LTD (DMF 21879, 36315), GLAXOSMITHKLINE LLC (DMF 32952, 31534), AARTI PHARMALABS LIMITED (DMF 22980), BREATHGREEN PHARMACEUTICAL CO LTD (DMF 38759), CURIA SPAIN SAU (DMF 37297) and Farmabios S.p.A. (DMF 20463) and 15 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Fluticasone Propionate records mean?
3 organisations have only inactive Type II DMFs for Fluticasone Propionate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Fluticasone Propionate have a European Certificate of Suitability?
Yes. 19 organisations hold a valid CEP for Fluticasone Propionate on the EDQM register, including TAPI NL B.V. Amsterdam (NL), CIPLA LIMITED Mumbai (IN), FERMION OY Espoo (FI), NEWCHEM S.p.A. Milan (IT), HOVIONE FARMACIENCIA S.A. Loures (PT) and VAMSI LABS LIMITED Solapur (IN) and 14 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Fluticasone Propionate?
Yes. The latest patent listed for an approved US product containing Fluticasone Propionate expires 23 Feb 2036, across 28 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Fluticasone Propionate supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Fluticasone Propionate?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.